These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2892955)

  • 1. [Internal neurology--a. Trends in the study of dementia and cerebrovascular disorders].
    Fukuyama H; Kameyama M
    Nihon Rinsho; 1987 Sep; 45(9):2125-32. PubMed ID: 2892955
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent advances in biochemical studies of dementia in the elderly].
    Nishimura T; Yamashita T; Tada K; Cacabelos R; Niikawa H; Suzuki H
    No To Shinkei; 1987 Jan; 39(1):9-16. PubMed ID: 2881562
    [No Abstract]   [Full Text] [Related]  

  • 3. [Calcium channel blockers and cerebral circulation].
    Uematsu D; Fukuuchi Y
    Nihon Rinsho; 1989 Aug; 47(8):1770-5. PubMed ID: 2585739
    [No Abstract]   [Full Text] [Related]  

  • 4. [Agents to improve cerebrovascular circulation and cerebral metabolism--calcium antagonists].
    Kyoi K; Utsumi S
    Nihon Rinsho; 1985 Feb; 43(2):368-71. PubMed ID: 3889411
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biochemistry of Alzheimer's disease].
    Mori H; Selkoe DJ
    Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1353-61. PubMed ID: 2162553
    [No Abstract]   [Full Text] [Related]  

  • 6. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
    Papasozomenos SC
    Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Abnormal proteins in the brain in Alzheimer's disease].
    Nukina N; Mannen T
    Tanpakushitsu Kakusan Koso; 1989 Sep; 34(12 Suppl):1725-32. PubMed ID: 2555845
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tau protein abnormality and dementia: the mechanisms of neurodegeneration].
    Tanaka T; Takeda M
    No To Shinkei; 2002 Sep; 54(9):777-87. PubMed ID: 12428364
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of chronic brain hypoperfusion in the pathogenesis of Alzheimer's disease--facts and hypotheses].
    Zádori D; Datki Z; Penke B
    Ideggyogy Sz; 2007 Nov; 60(11-12):428-37. PubMed ID: 18198789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Abnormal proteins in the brain in Alzheimer's disease].
    Kanemaru K; Ihara Y
    Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):2-11. PubMed ID: 1900947
    [No Abstract]   [Full Text] [Related]  

  • 11. [Calcium antagonists and cerebrovascular circulation].
    De Gregorio C
    Clin Ter; 1987 Oct; 123(1):41-50. PubMed ID: 2972466
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention, treatment, and resuscitation of cerebral ischemia.
    Illievich UM; Dumitrescu RV; Papousek A; Schreier H; Glaser C; Klimscha W
    Acta Anaesthesiol Scand Suppl; 1997; 111():95-9. PubMed ID: 9420970
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic cerebral hypoperfusion in a mouse model of Alzheimer's disease: an additional contributing factor of cognitive impairment.
    Lee JS; Im DS; An YS; Hong JM; Gwag BJ; Joo IS
    Neurosci Lett; 2011 Feb; 489(2):84-8. PubMed ID: 21134418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic principles of cerebral protection in humans.
    Lanier WL
    Liver Transpl Surg; 1999 Jul; 5(4):347-9. PubMed ID: 10388512
    [No Abstract]   [Full Text] [Related]  

  • 15. GSK3: a possible link between beta amyloid peptide and tau protein.
    Hernández F; Gómez de Barreda E; Fuster-Matanzo A; Lucas JJ; Avila J
    Exp Neurol; 2010 Jun; 223(2):322-5. PubMed ID: 19782073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tauopathy and Alzheimer disease: a full degenerating process].
    Buée L; Delacourte A
    Psychol Neuropsychiatr Vieil; 2006 Dec; 4(4):261-73. PubMed ID: 17194646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebral protective effects by continuous administration of a calcium antagonist after canine global brain ischemia--change in cerebral blood flow and metabolism].
    Ono K; Iwatsuki N; Obara S; Hashimoto Y
    Masui; 1988 Jan; 37(1):23-8. PubMed ID: 3367498
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Posttranslational modifications of microtubule associated protein tau].
    Miyasaka T; Takashima A
    No To Shinkei; 2002 Sep; 54(9):753-66. PubMed ID: 12428362
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cholesterol metabolic disorders and Alzheimer's disease].
    Hao JW; Li L
    Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):64-6. PubMed ID: 15881350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.